CBU
ADPT icon

CIBC Bancorp USA’s Adaptive Biotechnologies ADPT Stock Holding History

CIBC Bancorp USA’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$265K Buy
12,367
+997
+9% +$15.3K ﹤0.01% 1613
2026
Q1 		$158K Buy
+11,370
New +$181K ﹤0.01% 1649
2025
Q3 		$238K Buy
+15,931
New +$194K ﹤0.01% 1189

Other funds holding ADPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CIBC Bancorp USA's ADPT Position: Q2 2026 in Review

CIBC Bancorp USA increased its Adaptive Biotechnologies (ADPT) stake by 8.8% in Q2 2026, buying an estimated $15.3K and bringing the position to 12,367 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #1613.

CIBC Bancorp USA first reported a position in ADPT in Q3 2025 and has held it in 3 quarters since. 280 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • CIBC Bancorp USA held 12,367 shares of Adaptive Biotechnologies worth $265K as of Q2 2026.
  • CIBC Bancorp USA bought 997 Adaptive Biotechnologies shares in Q2 2026, an estimated $15.3K.
  • Adaptive Biotechnologies made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1613 holding.
  • CIBC Bancorp USA first reported a position in Adaptive Biotechnologies in Q3 2025 and has held it in 3 quarters since.
  • 280 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.